Publications by authors named "Brigitte Duclos"

Claim this Profile
E
Evaluation of axitinib to downstage cT2a renal tumours and allow partial nephrectomy: a phase II study.
Cedric Lebacle, Karim Bensalah, Jean-Christophe Bernhard, Laurence Albiges, Brigitte Laguerre, Brigitte Duclos

BJU Int· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Evaluation of the Impact of Antiangiogenic Treatment on Cognitive Functions in Metastatic Renal Cancer.
Florence Joly, Natacha Heutte, Brigitte Duclos, Sabine Noal, Isabelle Léger-Hardy

Eur Urol Focus· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Management of side-effects of targeted therapies in renal cancer: cardiovascular side-effects].
Stéphane Ederhy, Brigitte Duclos, Hakim Mahammedi, Jean-Dominique Doublet

Bull Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and patients' attitudes to oral anticancer drugs: a prospective series of 201 patients focusing on targeted therapies.
Philippe Barthélémy, Irène Asmane-De la Porte, Nicolas Meyer, Brigitte Duclos, Sebastian Serra

Oncology· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR inhibitors in advanced renal cell carcinomas: from biology to clinical practice.
Philippe Barthélémy, Benjamin Hoch, Christine Chevreau, Florence Joly, Brigitte Laguerre, Brigitte Duclos

Crit Rev Oncol Hematol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete remission with tyrosine kinase inhibitors in renal cell carcinoma.
Laurence Albiges, Stéphane Oudard, Sylvie Negrier, Armelle Caty, Gwenaëlle Gravis, Brigitte Duclos

J Clin Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New strategies for medical management of castration-resistant prostate cancer.
Irène Asmane, Jocelyn Céraline, Brigitte Duclos, Lynn Rob, Valère Litique

Oncology· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse primary angiosarcoma of the pleura: a case report and review of the literature.
Jean-Emmanuel Kurtz, Sebastian Serra, Brigitte Duclos, François Brolly, Patrick Dufour

Sarcoma· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of a granulocytic sarcoma of the uterine cervix in complete remission at six-year follow-up.
Stefano C H Kim, Shanti Natarajan-Ame, Bruno Lioure, Marie-Pierre Chenard, Brigitte Duclos

J Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line.
Gemma Marcias, Eva Erdmann, Gaëlle Lapouge, Christelle Siebert, Philippe Barthélémy, Brigitte Duclos

Hum Mutat· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adriamycin, cisplatin, ifosfamide and paclitaxel combination as front-line chemotherapy for locally advanced and metastatic angiosarcoma. Analysis of three case reports and review of the literature.
Irène Asmane, Valère Litique, Steve Heymann, Luc Marcellin, Anne-Cécile Métivier, Brigitte Duclos

Anticancer Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of temsirolimus combined with interferon alfa for advanced renal cell carcinoma.
Robert J Motzer, Gary R Hudes, Brendan D Curti, David F McDermott, Bernard J Escudier, Brigitte Duclos

J Clin Oncol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study.
Stéphane Oudard, Eugeniu Banu, Annick Vieillefond, Laure Fournier, Franck Priou, Brigitte Duclos

J Urol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Saccharomyces cerevisiae: an efficient tool and model system for anticancer research].
Jean-Emmanuel Kurtz, Patrick Dufour, Brigitte Duclos, Jean-Pierre Bergerat, Françoise Exinger

Bull Cancer· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer.
Jocelyn Céraline, Marion D Cruchant, Eva Erdmann, Philippe Erbs, Jean-Emmanuel Kurtz, Brigitte Duclos

Int J Cancer· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A yeast-based functional assay for the detection of the mutant androgen receptor in prostate cancer.
Jocelyn Céraline, Eva Erdmann, Philippe Erbs, Marion Deslandres-Cruchant, Didier Jacqmin, Brigitte Duclos

Eur J Endocrinol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis